These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cytochrome bc1-aa3 Oxidase Supercomplex As Emerging and Potential Drug Target Against Tuberculosis. Sindhu T; Debnath P Curr Mol Pharmacol; 2022; 15(2):380-392. PubMed ID: 34602044 [TBL] [Abstract][Full Text] [Related]
25. Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis. Arora K; Ochoa-Montaño B; Tsang PS; Blundell TL; Dawes SS; Mizrahi V; Bayliss T; Mackenzie CJ; Cleghorn LA; Ray PC; Wyatt PG; Uh E; Lee J; Barry CE; Boshoff HI Antimicrob Agents Chemother; 2014 Nov; 58(11):6962-5. PubMed ID: 25155596 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues. Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221 [TBL] [Abstract][Full Text] [Related]
27. Discovery of new leads against Mycobacterium tuberculosis using scaffold hopping and shape based similarity. Wavhale RD; Martis EAF; Ambre PK; Wan B; Franzblau SG; Iyer KR; Raikuvar K; Macegoniuk K; Berlicki Ł; Nandan SR; Coutinho EC Bioorg Med Chem; 2017 Sep; 25(17):4835-4844. PubMed ID: 28778369 [TBL] [Abstract][Full Text] [Related]
28. Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model. Knudson SE; Awasthi D; Kumar K; Carreau A; Goullieux L; Lagrange S; Vermet H; Ojima I; Slayden RA J Antimicrob Chemother; 2015 Nov; 70(11):3070-3. PubMed ID: 26245639 [TBL] [Abstract][Full Text] [Related]
29. Drug discovery in tuberculosis. New drug targets and antimycobacterial agents. Campaniço A; Moreira R; Lopes F Eur J Med Chem; 2018 Apr; 150():525-545. PubMed ID: 29549838 [TBL] [Abstract][Full Text] [Related]
30. Refined homology model of cytochrome bcc complex B subunit for virtual screening of potential anti-tuberculosis agents. Pan Z; Wang Y; Gu X; Wang J; Cheng M J Biomol Struct Dyn; 2020 Oct; 38(16):4733-4745. PubMed ID: 31674290 [TBL] [Abstract][Full Text] [Related]
31. Lansoprazole is an antituberculous prodrug targeting cytochrome bc1. Rybniker J; Vocat A; Sala C; Busso P; Pojer F; Benjak A; Cole ST Nat Commun; 2015 Jul; 6():7659. PubMed ID: 26158909 [TBL] [Abstract][Full Text] [Related]
32. In vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacterium tuberculosis. Knudson SE; Kumar K; Awasthi D; Ojima I; Slayden RA Tuberculosis (Edinb); 2014 May; 94(3):271-6. PubMed ID: 24746463 [TBL] [Abstract][Full Text] [Related]
33. Susceptibility of Mycobacterium tuberculosis Cytochrome Moosa A; Lamprecht DA; Arora K; Barry CE; Boshoff HIM; Ioerger TR; Steyn AJC; Mizrahi V; Warner DF Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760899 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of antimycobacterial activity of new benzimidazole aminoesters. Yoon YK; Ali MA; Wei AC; Choon TS; Ismail R Eur J Med Chem; 2015 Mar; 93():614-24. PubMed ID: 24996257 [TBL] [Abstract][Full Text] [Related]
35. Chemical Exploration of a Highly Selective Scaffold with Activity against Intracellular Njikan S; Ahmed S; Manning A; Awasthi D; Ovechkina Y; Chowdhury S; Butts A; Parish T Microbiol Spectr; 2022 Jun; 10(3):e0116122. PubMed ID: 35612308 [TBL] [Abstract][Full Text] [Related]
36. Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis. Gill C; Jadhav G; Shaikh M; Kale R; Ghawalkar A; Nagargoje D; Shiradkar M Bioorg Med Chem Lett; 2008 Dec; 18(23):6244-7. PubMed ID: 18930654 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
38. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064 [TBL] [Abstract][Full Text] [Related]
39. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates. Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500 [TBL] [Abstract][Full Text] [Related]
40. Mycobacterial Membrane Proteins QcrB and AtpE: Roles in Energetics, Antibiotic Targets, and Associated Mechanisms of Resistance. Bown L; Srivastava SK; Piercey BM; McIsaac CK; Tahlan K J Membr Biol; 2018 Feb; 251(1):105-117. PubMed ID: 29098330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]